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The serologic response to two commercial infectious bronchitis 
vaccines was determined in broiler chicks in this study. The vaccine 
virus strains used were Ma5 and H120. Chicks were vaccinated at 5 and 10 
days old, via intraocular and drinking water. Enzyme – linked 
immunosorbent assay (ELISA) was used to monitor the serologic 
response to the vaccines. 
Serum samples were tested before vaccination and at 15, 20, 25 
post vaccination. The two commercially live IB vaccines give good 
immunological responses in chicks even when used in relatively high 
MDA chicks. No clinical symptoms nor postmortum findings were 
observed following administration of the vaccines. However body 
weight measurement resulted in that H120 strain is influencing to the 
body weight gain when used via drinking water at 5 – day – old as 
compared to other vaccination protocols. 
Generally H120 gave good response than Ma5, while 5 day – old 
vaccination gave better response than 10 day – old vaccination and 
intraocular route resulted in high antibodies than drinking water route. 
The result of this study are additional support for suitability of ELISA 
test as a sensitive and rapid serological test for IBV antibodies detection. 
In conclusion the immunogenicity of H120 was observed to be 
better than of Ma5 with non significant variation noted, and its effective  
to used as initial vaccine in the first week or when ever time of 
vaccination was lost. Also conclude that time of vaccination influenced 
the effectiveness of the vaccine, so early vaccination is recommended.  
 اﻟﺨﻼﺻﺔ
 
 aM5.و 021H)اﻟﺘﻬѧﺎب اﻟѧﺸﻌﺐ اﻟﻤﻌѧﺪي اﻟﺤﻴѧﺔ ﻤﻘѧﺪرة اﻟﺘﺤѧﺼﻴﻨﻴﺔ ﻟﻠﻘﺎﺣѧﺎت  ﻟﻘﺪ ﺗﻢ إﺟﺮاء دراﺳѧﺔ ﻗﻴѧﺎس اﻟ 
 اﺳﺘﺨﺪﻣﺖ اﻟﻠﻘﺎﺣﺎت ﻣѧﻦ ﺗﺠﺎرﻳًﺎ ﻓﻲ اﻟﺴﻮدان، ﺣﻴﺚ أﺟﺮﻳﺖ اﻟﺪراﺳﺔ ﻓﻲ آﺘﺎآﻴﺖ ﻟﺤﻢ ﻧﺎﻣﻲ ﺳﻼﻟﺔ هﻴﺒﺮد اﻟﻤﺴﺘﺨﺪﻣﺔ 
   . أﻳﺎم01 و 5ﻋﻤﺮ   ﻓﻲﻟﺘﻘﻄﻴﺮ ﺑﺎﻟﻌﻴﻦ وﻣﺎء اﻟﺸﺮبﺧﻼل 
 اﻟﻠﻘﺎﺣѧﺎت،  ﺑﻌѧﺪ اﺳѧﺘﺨﺪام 52، 02، 51 ﻓѧﻲ اﻟﻴѧﻮم  ﻗﺒѧﻞ اﺳѧﺘﺨﺪام اﻟﻠﻘﺎﺣѧﺎت ﺗﻢ ﻓﺤﺺ اﻟﻌﻴﻨﺎت اﻟﺘѧﻲ ﺟﻤﻌѧﺖ 
 . ﻟﻘﻴﺎس اﻟﻤﻘﺪرة اﻟﺘﺤﺼﻴﻨﻴﺔﻴﺰاﺑﺈﺟﺮاء اﻻﺧﺘﺒﺎر اﻟﻤﺼﻠﻲ اﻹﻟ
أآﺪت اﻟﻨﺘﺎﺋﺞ أن اﻟﻠﻘﺎﺣﺎت ذات آﻔﺎءة ﻋﺎﻟﻴﺔ وﻣﺄﻣﻮﻧﺔ ﺣﺘﻰ ﻋﻨﺪ اﺳﺘﺨﺪاﻣﻬﺎ ﺑﻮﺟﻮد أﺟﺴﺎم ﻣѧﻀﺎدة ﻣﻜﺘѧﺴﺒﺔ 
 . ﺑﻌﺪ اﺳﺘﺨﺪاﻣﻬﺎ أو ﺗﺸﺮﻳﺤﻴﺔوﻟﻢ ﺗﻈﻬﺮ أي أﻋﺮاض ﺳﺮﻳﺮﻳﺔ( ﻣﻨﺎﻋﺔ ﻋﺎﻟﻴﺔ)ﻣﻦ اﻷﻣﻬﺎت 
  ذات ﺗѧѧﺄﺛﻴﺮ ﺳѧѧﻠﺒﻲ ﻗﻠﻴѧѧﻞ ﻋﻠѧѧﻰ زﻳѧѧﺎدة اﻟѧѧﻮزن ﺣѧѧﻴﻦ 021Hﻋﻨѧѧﺪ ﻣﺮاﻗﺒѧѧﺔ وﻗﻴѧѧﺎس اﻷوزان ﺗﺄآѧѧﺪ أن اﻟﻌﺘѧѧﺮة 
 ﺗﺤѧﺪث ﻣﻨﺎﻋѧﺔ ﻋﺎﻟﻴѧﺔ ﻣﻘﺎرﻧѧﺔ 021Hﺑѧﺼﻔﺔ ﻋﺎﻣѧﺔ ﻓѧﺈن اﻟﻌﺘѧﺮة .  أﻳѧﺎم ﻣѧﻦ ﺧѧﻼل ﻣѧﺎء اﻟѧﺸﺮب5 اﺳѧﺘﺨﺪﻣﺖ ﻓѧﻲ ﻋﻤѧﺮ
آﺬﻟﻚ اﺳﺘﺨﺪام اﻟﻠﻘﺎح ﻋﻦ ﻃﺮﻳﻖ ﻣﺎء اﻟﺸﺮب ﻳﺤﺪث ﻣﻨﺎﻋﺔ أآﺜﺮ ﻣﻦ اﺳﺘﺨﺪاﻣﻪ ﺑѧﺎﻟﻌﻴﻦ، أﻣѧﺎ اﺳѧﺘﺨﺪام . 5aMﺑﺎﻟﻌﺘﺮة 
 .     أﻳﺎم01 ﻣﻨﺎﻋﺔ أآﺒﺮ ﻣﻦ اﺳﺘﺨﺪاﻣﻪ ﻓﻲ ﻋﻤﺮ  أﻳﺎم ﻳﺤﺪث5اﻟﻠﻘﺎح ﻓﻲ ﻋﻤﺮ 
أآﺪت اﻟﺪراﺳﺔ أن اﻻﺧﺘﺒﺎر اﻟﻤﺼﻠﻲ اﻹﻟﻴﺰا ﻳﻨﺎﺳﺐ ﻗﻴﺎس اﻟﻤﻘѧﺪرة اﻟﺘﺤѧﺼﻴﻨﻴﺔ ﻧѧﺴﺒﺔ ﻟѧﺴﺮﻋﺘﻪ وﺣѧﺴﻴﺎﺳﻴﺘﻪ 
 . ﻟﻘﻴﺎس اﻷﺟﺴﺎم اﻟﻤﻀﺎدة
وﺗﺤѧﺪث ﻣﻨﺎﻋѧﺔ ﺟﻴѧﺪة ﻋﻨѧﺪ .5aM ﺣﻤﺎﻳѧﺔ أﻋﻠѧﻰ ﻣѧﻦ اﻟﻌﺘѧﺮة  ﺗﻈﻬѧﺮ021Hﻧﺨﻠѧﺺ اﻟﺪراﺳѧﺔ إﻟѧﻰ أن اﻟﻌﺘѧﺮة 
وأﻳѧﻀًﺎ اﺳﺘﺨﻠѧﺼﺖ . اﻟѧﺰﻣﻦ اﻟﻤﺤѧﺪد ﻻﺳѧﺘﺨﺪاﻣﻬﺎح أول ﺑѧﺎدي ﻓѧﻲ آﺘﺎآﻴѧﺖ ﻋﻤѧﺮ ﻳѧﻮم وآﻠﻤѧﺎ اﻓﺘﻘѧﺪ اﺳѧﺘﺨﺪاﻣﻬﺎ آﻠﻘѧﺎ
ﻟﻠﻘѧﺎح وﺗﻮﺻѧﻲ اﻟﺪراﺳѧﺔ ﺑﺄهﻤﻴѧﺔ اﺳѧﺘﺨﺪام اﻟﻠﻘѧﺎح ﻓѧﻲ اﻟﺪراﺳﺔ أن زﻣﻦ اﻟﻠﻘﺎح ﻋﺎﻣﻞ ﻣﺆﺛﺮ ﻋﻠﻰ اﻟﻤﻘѧﺪرة اﻟﺘﺤѧﺼﻴﻨﻴﺔ 
  .اﻻﺳﺒﻮع اﻷول
INTRODUCTION 
 
         Infectious bronchitis  (IB) was first  identified  in 1931 in the  USA as a new 
respiratory disease of baby chicks, that caused by coronavirus. Infection with avian 
infectious bronchitis virus (IBV) may result in  a short – lived, self limiting 
respiratory disease or progress to generalized systemic infection. Egg production and 
egg quality problems were first attributed to the same virus in 1951 and a syndrome 
of kidney damage in 1962, since then the disease has been a consistent and 
significant feature of poultry production causing tremendous economic losses to the 
poultry industry thought out the world. The virus is present  in respiratory secretion 
and feces and  disseminated by aerosol. Mechanical transmission of the virus by man 
and contamination of clothes and equipment play important role in the disease 
spread. Infectious bronchitis virus (IBV) replicates not only in respiratory tissues 
causing respiratory disease, but  also in kidneys (associated with  minor or major 
nephritis), oviducts and in many parts of the alimentary tract (oesphagus, 
proventriculus, duodenum, jejunum, bursa of fabricius, caecal tonsils, rectum and 
cloaca) usually  without clinical effects. 
Infectious bronchitis virus is identified to posses two antigenic types, so 
immunization of susceptible chickens with one antigenic type of the virus has been 
shown to induce partial or no protection against unrelated types. So, the vaccine must 
contain different local strains to control the disease. 
Infectious bronchitis continues to be a problem in chicken flocks, despite the 
general use of live, attenuated vaccine, primly because new serotypes continue to 
develop. 
In Sudan, the disease was first reported by Gaffar Elamin et al. (1986), since 
then many outbreaks were recorded and diagnosed (Borhan, 1995;Anon, 2000, 
Ballal, 2003). A host’s immune response to natural infection or to administration of 
live attenuated or inactivated virus depend on a number of factors related to virus 
strain, route of administration, method of exposure and immunologic status of the 
chicken. It is, therefore, of great importance, for efficient vaccination programme in 
Sudan to evaluate immunocompetancy of chicken flocks in local condition. The 
present work was conducted  to achieve the following goals: 
i. To evaluate the effectiveness of two commercial IB vaccines (H120 and Ma5). 
ii. To determine the influence of timing of vaccination on the effectiveness of the 
vaccine. 
iii. To evaluate the efficiency of ELISA technique to monitor the antibodies  











REVIEW OF THE LITERATURE 
 
1.1 Definition 
Infectious bronchitis (IB) is an acute, highly contagious viral respiratory 
disease of chicken flocks, that caused by corona virus (Lin et al., 2005). The disease 
is characterized by coughing, sneezing, tracheal rals, nasal discharges specially in 
young baby chicks, and gasping. The disease sometime refer to as gasping disease 
(Borhan et al., 1995). The disease is of considerable significance to poultry industry 
since it has been known to cause adverse effect on egg production and egg quality in 
layers as well as appreciable losses among broilers and high mortality in baby chicks 
(Hofstad 1985; Lin et al., 2005). Infectious bronchitis virus (IBV) shows tropism to 
respiratory tract, reproductive tract, kidneys and alimentary tract  (Cavanagh, 2003 ). 
Miller and Yates (1968) reported the presence of antibodies against IBV in 
human sera from individuals associated with poultry. However, according to Hofstad 
(1978) and Pederssden et al., (1990), IB appear to be of no public health 
significance, despite the fact that higher levels of antibodies may be due to direct 
exposure to the virus rather than being a zoon tic infection. 
1.2 Historical background 
Infectious bronchitis (IB) was first reported by Schalk and Hawn (1931) who 
observed the disease in spring of 1930 in North Dakota, U.S.A. The disease was then 
recognized in almost all parts of the United States and eventually other parts of the 
world. 
Earlier reports indicated that IB was primarily a disease of young chicks. 
However, it was later observed to be common in semi – immature and laying flocks 
(King and Cavanagh, 1991; Cavanagh, 2003 ). Egg production and egg quality 
problems were first attributed to the same virus in 1951 as well as a syndrome of 
kidney damage in 1962 (Cavanagh, 2003). Recently, the etiologic virus has been 
recovered from the digestive tract (Ambali and Jones, 1990; Luico and Fabricant, 
1990). 
1.3 Incidence and distribution 
Infectious bronchitis disease is ubiquitous with worldwide distribution. In the 
Sudan, IB was recorded when the virus was isolated for the first time in Eastern 
Sudan, from an outbreak of a respiratory disease occurred in February 1981 during 
the cold dry winter (El amin  et al., 1986). 
1.4 The causative agent 
Infectious bronchitis is caused by a member of the genus coronavirus, of the 
family Coronaviridae, which is a family of positive sense, RNA, helical enveloped 
viruses that infect mammals  and birds  (Jamieson, 1998) , of the new order 
Nidiovirales (Murphy et al., 1999). The family includes another genus torovirus 
(Berne virus and Breda virus). In addition to IBV , the genus coronavirus comprises 
other animal viruses. They Include turkey blue comb virus, transmissible 
gastroenteritis virus and haemagglutinating encephalomyelitis swine virus, calf 
coronavirus, feline infectious peritonitis virus and feline enteric coronavirus, human 
coronaviruses 229E, OC43 and another five virus species in mammals (Murphy et 
al., 1999). The severe  acute  respiratory syndrome (SARS) which caused outbreaks 
in avian species and human in south east Asia recently was also classified as corona 
virus (Rota et al., 2003). 
1.4.1 Classification 
Infectious bronchitis virus (IBV), together with the genetically related 
coronaviruses of turkey is a group 3 coronavirus, severe acute respiratory syndrome 
(SARS) coronavirus  being  in group 4, the other  known mammalian  coronaviruses  
being in group 1 and 2 (Cavanagh, 2003). 
The classification of IBV has been attempted by Cunningham (1970). IBV is 
a member of  the family Coronaviridae which include single genus coronavirus. 
Coronaviruses are grouped together on the basis of their morphology, ether liability 
and their single – stranded RNA genome (Tyrrell et al., 1968). 
1.4.2 Structure of the virus 
The word corona means (crown), because of the envelope proteins  look 
under an electron microscope (Jamieson ,1998) . Negatively – stained preparations of 
coronaviruses from chicken flocks (Uppal and Chu, 1970) show pleomorphic but 
approximately spherical virions 60 to 120 nm in diameter. Cunningham (1966) 
estimated the size of IBV particle as 80-100 nm. The virus particle has characteristic 
club - shaped projections which are approximately 20 nm long and 10 nm wide 
(Hofstad, 1978). 
Coronavirus virions are enveloped, 80-220 nm in size, roughly spherical in 
shape (Cavanagh, 1997; Murphy et al., 1999). 
Three virus – specific proteins have been identified, the spike (S) 
glycoprotein, the membrane or matrix (M) glycoprotein and the nucleocapsid (N) 
protein (Butcher et al; 1998). The spike glycoprotein of two glycopolypeptides (S1 
and S2) and these spikes or peplomers could be seen projecting through the envelope 
on electron micrographs giving the virus its characteristic shape  “corona” (Butcher 
et al., 1998). 
1.4.3 Virus genome organization 
The genome of IBV consists of a single stranded RNA molecule, about 27-32 
Kb in size being the largest RNA virus genomes known. These viruses have the 
ability to genetically recombine with other members of the coronavirus family, and 
has a unique method of replication ( Koopmans and Marion 1993). The precise 
strategy used by coronaviruses for genome replication is not  yet known (Brian and  
Baric, 2005). Transcription of genomic RNA yielded full length complementary 
RNA that act as a template for the synthesis of a nested set of five to seven sub 
genomic mRNAs (Murphy et al., 1999). 
1.4.4 Stability 
Infectious bronchitis  virus is labile, easily destroyed by disinfectants, heat, 
sunlight and other environmental factors (Staylganov 1971; Otsuki et al., 1979). All 
strains rapidly lost their infectivity upon heating at 56°C for 15 minutes and 
ultraviolet irradiation and completely inactivated by sodium deoxycholate and 
chloroform, but some strains were relatively stable. Trypsin did not affect the 
infectivity of any strain. Although most strains were sensitive to pH 11.0 but some of 
them were resistant to pH 3.0 (Otsuki et al., 1979). 
1.4.5 Biological properties 
Untreated antigen of IBV does not agglutinate avian erythrocytes. However , 
the heamagglutinin of Connecticut strain was detectable after sucrose gradient 
purification (Bingham et al., 1975) , whereas the haemagglutinin of M41 strain 
required the purification step as well as an additional incubation with enzyme 
phospholipase C type one to reveal its heamagglutinin. Only 4 out of 9 strains treated 
similarly appeared to  show haemagglutinating activity (Alexander et al., 1976). 
1.4.6 Strain classification 
Infectious bronchitis in avian species  was considered to be caused by a single 
antigenic type of the virus till 1956. However, it was later recognized that IBV  
isolates exhibit extensive biologic variations (Hofstad, 1984). The IBV  genome 
consisted of a single stranded RNA. Like many other RNA viruses, IBV has a high 
error rate during the replication of its genomes (Lai and Cavangh, 1997). This is 
mainly due to the fact that RNA polymerase lacks, the 3 َ - 5 َ exonuclease activity 
(editing function) of DNA polymerase (Garreh andCrisham, 1999).            
Infectious bronchitis virus have many strains: Holland, Massachusetts 41 
(4Ms), Connecticut 46; Florida 18288 and Arkansas (Ark 99), SE 17, Baudette and 
other. Each strain with many serotypes, that antigenically  different which are known 
by neutralization test, and  is probable new serotypes appear from time to time 
(Hofstad, 1981; Brian  and  Baric, 2005). New  IBV  serotypes and genotypes can 
emerge as a result of only  very few changes or mutations in the sequence of the 
spike gene, or as a result of genome recombination during mixed infections. This 
could be promoted by the use of more than one vaccine strains or by a mixture of 
vaccine and wild viruses (DeWit 2000). 
The classification systems of  IBVs  are divided into two major groups: 
functional tests that regard the biological function of a virus, results in immunotypes 
or protectotypes and antigenictypes.  And non- functional test that look at the viral 
genome result in genotypes (DeWit, 2000). 
1.5 Serology 
The serological tests are used for the following purposes: 
1.5.1 Virus identification 
The presence of an IBV antigen has to be confirmed by detection methods 
such as Immuno - Fluorescence Assay (IFA), Enzyme Linked Immunosorbent Assay 
(ELISA) and Agar Gel Precipitation (AGP) (DeWit, 2000). 
1.5.2 Serotype determination 
Many investigators have studied the strain differences among IBV and 
attempted to determine the serotypes and classify them by using different procedures 
such as plague reduction test (Hopkins, 1974), neutralization test (Johnson and 
Marquardt, 1975; King and Cavanagh, 1991). The differences in molecular weight of 
the major glycopolypeptides (Collins and Alexander, 1980), the oligonucleotide 
finger printing of RNAs (Clewley et al., 1981), heamagglutination inhibition test 
(King and Hopkins, 1984). 
1.5.3 Monitoring of the vicinal response  
Serum antibody assays have been routinely employed for IBV to monitor the 
vacinal response and to  measure titer of antibody due to field infection. The 
serological tests used according to Hofstad (1978) include the following: 
i. Heamagglutination inhibition test.(HI). 
ii. Agar gel precipitation test (AGPT). 
iii. Fluorescent antibody technique (FAT). 
iv. Virus neutralization tests  (VNT). 
v. Plague reduction technique   (PRT). 
vi. Complement fixation test (CFT). 
vii. Enzyme – linked immunosorbent assay (ELISA). 
1.5.3.1 Enzyme – linked immunosorbent assay (ELISA) 
ELISA technique is one of the most sensitive serological methods gives an 
earlier reactions and higher antibody titers  than any other test (Mochett and 
Darbyshire, 1981). It lacks type or strain specificity, but it is suitable for monitoring 
vaccination responses  under field conditions (Case et al., 1983). The technique was 
also used for monitoring circulating IBV  antibody levels as well as in detection of 
serological responses to infection (Nadapalan, 1982; Case et al., 1983). As a 
confirmation test, ELISA is more suitable  for the detection of IBV antigens in 
allantoic fluid of inoculated eggs, especially when a large number of samples has to 
be tested (De Wit, 2000). Mochett and Cook (1986) applied the test for detection of 
specific IgM  to IBV in serum samples from infected chickens. 
Infectious Bronchitis virus antibody test kit 
These  are used  for assessment of immune status, as well as serological 
identification of IBV which require the measurement of antibody to IBV in a serum. 
Enzyme – linked immunosorbent assay systems have proven effective in a 
quantification of antibody levels to IBV, and facilitate the monitoring of immune 
status in large flocks (Case, 1983).                                                           
1.5.3.2 Polymerase chain reaction (PCR) 
 In recent years, the reverse transcription – polymerase chain reaction (RT – 
PCR) for RNA – containing viruses have been increasingly used (Cavanagh, 1993 ). 
Lin et al. (1991b) studied the use of the RT – PCR to amplify part of the S2 region of 
the S gene of  IBV isolates. As reviewed by Cavanagh (1995) the most variable part 
of the S gene is the S1 region, which encode amino acids involved in the induction of 
neutralization (VN) and haemagglutination inhibiting (HI) antibodies and protective 
immunity. Kwon et al (1993) designed a pair of oligonucleotides primers to generate 
a 1.7 kb cDNA from this S1 region from 8 North American serotypes. These results 
suggested a design of an IBV – specific oligonucleotides to act as a universal pairs 
that means to generate cDNA with any isolate of IBV in RT – PCRs (Adzhar et al., 
1996).      
1.5.3.3 Agar gel Precipitation test (AGPT)  
  Usually, the antigen used in AGPT is prepared from a homogenate of  
choriallantoic membranes (CAM) or from allantoic fluid (AF) of an IB infected 
chicken embryos. Although the test has an image of poor sensitivity as the presence 
and duration of precipitating antibodies may vary with individual birds. However, the 
test was comparable in sensitivity to that of the more recent tests when used directly 
in specimens from infected birds (DeWit, 2000).   
1.5.3.4 Haemagglutination inhibition (HI) test 
 Haemagglutinating activity of IBV was described by Bingham et al. (1975) 
for the first time. Several strains of IBV haemagglutinated chicken erythrocytes after 
pretreatment of the virus with the enzyme phospholipase – C – type -1 (Alexander et 
al ., 1983). However, it was found to be more efficient to use crude filtrate from 
Clostridium perfringens cultures. Schultze et al. (1992) had the opinion that the 
enzyme responsible for the treatment is most probably neuraminidase, hence 
treatment with Clostridium perfringens crude filtrate gave better result than with 
phospholipase alone (Davelaar et al., 1983).  
 Alexander et al. (1983) developed a standard technique for HI test. Later 
Lashgari and Newman (1984) used the test in the determination of antigenic 
relationships among IBV serotypes. In comparative studies, Gough and Alexander 
(1978) showed that IBV antibody was detected earlier by HI test than VN test, thus, 
establishing the value of HI test for diagnosing IBV and monitoring the vacinal status 
of flocks (King and Hopkins, 1983; Cook  et al., 1987).   
1.6 Economic importance 
Infectious bronchitis get economic importance because: 
1. Infectious bronchitis virus causes high mortality in young chicks, reduction of 
feed conversion and decrease of weight gain among infected chicks (Hofstad, 
1984).  
2. In broiler flocks, susceptible flocks infected with IBV may experience 
mortality rates of up to 25% (King and cavanagh, 1991). The feed conversion 
and weight gain were also impaired and higher condemnation rates due to air 
sacculitis were recorded in flocks infected with IBV  together with other 
respiration tract infections (e.g. E. coli  and mycoplasma infections) 
(Bremner, 1995; Yogaratnam, 1995).  
3. Among breeder and layer flocks (up to six weeks of age) infected with IBV 
during the early rearing period with mortality rates up to 25% were recorded 
(King and Cavangh, 1991; Gough et al., 1992; Parsons et al., 1992). In adult 
birds, mortality did not normally occur. However, the new 4/91 strain of IBV 
in the UK had been associated with deaths in adult birds (Parsons et al., 
1992) and a patterns of  sharp rise mortality over a period of few days was 
observed. A drop in egg productions up to 30% were recorded among laying 
hens infected with IBV with recovery within  3-4 weeks (Gough et al., 1992).    
1.7 Host 
 The early reports referred to IB primarily as a disease of baby chicks. The 
virus is believed to have migrated from chicks, so chicken was not the only natural 
host for IBV (Hofstad, 1984). In 1988, the isolation of IBV from racing pigeons with 
respiratory disease was described by Barr et al. (1988). Nair et al., (1991) described 
an outbreak of IB – like disease in Guinea fowls. Also coronavirus-like viruses were 
isolated from  a peafowl and  teal,  they were act as carriers (Liu et al., 2005).                                 
1.8 Transmission 
i. Infectious bronchitis virus is transmitted from bird to bird through the 
respiratory route in droplets expelled during sneezing or coughing by infected 
chickens. Spread through a flock is very rapid and infected chicken might 
remain carrier, the virus can persist, being re-excreted at the onset of egg 
laying(4 to 5 months of age), and shed the virus for several weeks (King and 
Cavanagh 1991, 2003) Also peafowl and teal (carrier host) may transmit 
virus to susceptible chicken (Liu et al ., 2005). The disease transmission 
between chicken houses and even from farm to farm was related to the 
movement of contaminated equipment, people, and vehicles. Transmission 
through egg was not seem to be a significant route of spread (Lister, 1998). 
1.9 Clinical signs 
ii. In broilers, respiratory tract infection, with highly contagious respiratory 
disease with gasping, coughing, sneezing, nasal discharge, conjunctivitis and 
swollen sinuses. It also depress weight gain and had an adverse effect on feed 
conversion ratio, diarrhea and poor feed utilization. Certain IBV strains 
seems to target the kidneys leading to severe kidneys damage, morbidity, 
dehydration and death (Cook and Huggins, 1986).   
iii. In young chicks, the virus infect young layers less than two weeks of age lead 
to permanent effect on the developing reproductive tract, the oviduct fail to 
mature leaving the pullet as a “false” or “blind” layer or breeders. Urinary 
tract infection of young chicks in picture of kidney damage could lead to the 
deposition of urate crystals on internal organs rather than their normal 
excretion with feces (visceral gout). Also, damage might cause kidneys 
stones (urolithiasis) leading to destruction of one or both kidneys (Lister, 
1998). 
iv. In layers, adverse effects on egg production due to reproductive tract 
infection with or without respiratory signs followed by an increase in egg 
quality problems such as deformed eggs with wrinkled shells and poor quality 
albumin or “watery whites” and death due to egg peritonitis (Cook and 
Huggins, 1986).  
1.10 Diagnosis 
1.10.1 The clinical picture  
The clinical signs, mentioned previously ,are highly suggestive.                                   
1.10.2 Post mortem findings 
Hofstad  (1978) described the gross lesions of infectious bronchitis – infected 
chickens as follows  
i. Serous, catarrhal, or caseous exudates was observed in trachea, nasal passages 
and sinuses. 
ii. The air sacs may appear cloudy. 
iii. Caseous plug may be found in lower trachea or bronchi, the oviduct  length and 
weight were markedly reduced and permanent damage of the oviduct resulting 
in false layers. 
1.10.3 Histopathology 
i. The main microscopic lesions in the respiratory tract include cellular 
infiltration and edema of the mucosa and sub mucosa, vascular congestion, 
hyperplasia, vacuolation of epithelium and hemorrhages of the submucosa 
(Hofstad, 1978). Hyperplasia was described by McDonald and McMartin, 
(1970) in mild  cases of IBV infection. 
ii.  The main lesion of the oviduct was found to be localized hyperplasia (Crinion 
and Hofstad, 1971). Also a mild reduction inepithelium linings with 
lymphocytic infiltration, degeneration, cellinfiltration and necrosis of muscular 
cell layers (Muscularismucosa) were seen in oviduct.    
iii. Kideys were filled with cast deposition , degenerated tubules with loss of 
epithelium and focal segmental necrosis. Tubular edema, hyperemia diffuse 
hemorrhages were observed as pink   points (Ballal, 2003). 
1.10.4 Detection of virus antigens 
Field strains of IBV can be isolated using embryonated eggs, tracheal organ 
cultures and cell culture. The presence of an IB virus antigen has to be confirmed by 
detection methods such as IFA, ELISA, AGPT and PCR (De Wit, 2000). 
(i) Embryonating chicken eggs 
Inoculation of 9-11 day – old embryonating chicken eggs in allantoic cavity 
with the suspected suspension of an IBV has been recommended particularly for 
isolation attempts (Lukert, 1980). As many isolates are difficult to isolate on the first 
inoculation, the process of blind passage has been suggested to continue for at least 5 
serial passages (Hofstad, 1984). Dwarfing of few embryos with 90% survival 
through the 19th day of inoculation has been considered characteristic for IBV field 
material during the initial inoculation in 9 to 11 day – old embryonating chicken 
eggs. Curled embryos, thickened amniotic membrane, decreased volume of amniotic 
fluid, shrunken yolk sac, persistent mesonephros containing urates and increased 
volume of clear allantoic fluid are alterations of embryos due to virus growth 
(Hofstad, 1984).   
(ii) Tracheal organ culture (TOC)  
 The first assay of IBV in TOC inducing ciliostasis was done by Johnson et al. 
(1969). The technique (TOC) was used for classification of IB virus strains. 
Moreover, TOC has also been used  for the assessment of vaccination status  and 
cross immunity in chickens to various serotype of IB virus (Darbyshire et al., 1979, 
1980; Locher et al., 1983). TOC was also compared to HI and SN test for typing of 
IBV and proved to be more  sensitive (Cook et al., 1987).  
(iii) Cell cultures 
 The use of cell cultures for primary isolation of IBV is impractical since 
blind passage process in embryonating eggs is required before the virus grows well 
in cell cultures of chick kidneys or chicken embryos (Lukert, 1969; Hopkins, 1974). 
Otsuki et al. (1979) propagated IBV in chick kidney cells and fibroblast cultures. 
They found that chick kidney cells were the superior. The lag phase of IBV in chick 
embryo kidney (CEK) or chick kidney cells (CK) was found to be 3-4 hours with 
maximum titers in the culture medium being at 14-36 hours, leaning on the 
multiplicity of infection (Darbyshire  et al., 1975; Otsuki et al., 1979). Alexander 
and Collins (1975) observed syncytia six hours after inoculation with IBV Beaudette. 
After 18-24 hours the syncytia contained 20-40 or more nuclei and became 
vacuolated.  
1.11 Control of IB   
Infectious bronchitis is mainly  controled  by vaccination.                      
1.11.1 Immunization against infectious bronchitis virus 
1.11.1.1 Passive  immunity   
Maternal antibody can lessen both severity of vacinal reaction and the 
efficacy of the vaccine if the vaccine is of the type employed in the immunization of 
the breeder flock  (Klieve and Cainming, 1988). Mockett et al. (1987) found 
maternal antibodies that protect against challenge at one week but not   two weeks of 
age. It has been demonstrated by Cunningham (1970) and Hofstad (1984) that 
maternally derived antibody (MDA) does not prevent viral infection of the 
respiratory tract but does reduce the pathogenic effects of IBV infection in young 
chicks. 
1.11.1.2 Active immunity 
 Chickens recovered from a natural infection of IB induce antibodies (Hofstad, 
1978). It takes about 3 weeks for chickens to reach high levels of antibodies after 
exposure to bronchitis virus.  
1.11.2 Infectious bronchitis vaccination 
 The first immunization procedure used against IBV started about 1941, It 
consisted  of inoculating a small portion of the birds in a flock 7-15 weeks of age 
with a field strain of IBV and allowing natural spread to the rest of the flock, after 
recovery the flock would be immune. Modified live IB vaccine were first used in 
1950 (Butcher et al., 1998) both live and inactivated virus vaccines are now used in 
IB immunization. 
 Timing of initial immunization with IB vaccine varies due titer of maternal 
antibody in chicks and vaccination method (Hofstad, 1984). The passive antibodies 
did not maternally influence immune response to live virus as judged by challenge 
(Hofstad, 1984).      
 There are many different strains of the IBV  and new forms are continually 
emerging. Strains vary in virulence from a pathogenic to highly virulent, they also 
differ in their effects on the host, all strains readily infect the respiratory tract but 
only some strains affect the kidneys and or reproductive tract of chickens, (Hofstad, 
1984). 
 These features of IB mean that the economic impact of the disease in the 
national flock will vary over time depending on the effectiveness of available 
vaccines to combat them , severe outbreaks of the IB often occur when a new strain, 
which is distinct from vaccine strain, enters a population (Lin et al., 2005).  
1.11.3 Types  of IB vaccines 
1.11.3.1 Live IB vaccines 
 Live IBV vaccines are used in broilers and for the initial vaccination of 
breeders and layers (Klieve and Cumming, 1988). The vaccines can be administered 
individually by eye – drop or into the nostril. Mass application methods include 
coarse spray, (day – old chicks only), aerosol (not broilers), and drinking water 
(Andrade  et al., 1983).  
1.11.3.2 Inactivated  IB vaccine 
 Inactivated IBV  vaccines are used primarily at point of  lay  in breeders and 
layers, they require injection of individual birds. They are usually given after 
(priming) with live vaccine and are administrated a few weeks before egg production 
commences (Stone et al., 1978). They may be given in combination with other 
inactivated vaccines, for example, New castle disease, egg drop- Syndrome and 
infectious bursal disease vaccines, (Mcllroy, 1994).  
1.11.3.3 Vaccination Schedules 
Typical vaccination schedules are given below as mentioned by producer( 
Intervet International B.V. Boxmeer- Holand). 
(a)Broilers 
 A live, highly attenuated vaccine (strain H120) at one day old via coarse spray. 
This may be repeated at 18-21 day, in high risk areas using alive vaccine in drinking 
water (IB Ma5 and 4/91). 
(b) Breeder and layers 
i. Live vaccine (H120) in drinking water at 3 and 8 weeks of age followed by 
killed vaccine at 16-18 wks of age, or 
ii. At one day – old (coarse spray) and at 5 weeks of age (drinking water), aerosol 
followed by killed vaccine at 16-18 weeks of age, or 
iii. Live vaccine (H120) at day old (or week of age), followed by the less 
attenuated live vaccine strain H52 or the new live vaccine 4/91.  
     The live vaccine H52 must not be used as the first vaccine in a flock nor in 
flocks in which the killed vaccine will be used.  
1.11.3.4 Effectiveness of IB vaccines 
The effectiveness of IB vaccines depends on whether the strain(s) in the 
vaccine confer protection against the strain causing disease in a flock. The vaccines 
available in the UK largely contain Massachusetts strains of IBV, e.g. Ma5, M41, 
H120, these vaccines proved ineffective against IB in UK since 1991 (Parsons et al., 
1992). A live vaccine against strain 4/91 become available in the UK at the end of 
1995. The frequency of use of different vaccines is not known. However, at least one 
major broiler grower is using the new vaccine, Nobilis IB4-91, to protect all their 
birds.  
1.11.3.5 Cross protection of IB vaccine  
There  are different IB serotypes that show little cross protection, so it is 
difficult to control the disease because there is no one vaccine strain or combination 
of strains that produces complete cross - protection against the variant IB serotypes. 
However, some vaccines offer more protection than others (Ballal , 2003 ).  
The H strain of IBV  was one of the earliest live attenuated  IB vaccine, it has 
the ability to provide heterologous cross-protection against a number of IBVs of 
different serotypes (Bijlenga et al., 2004). The classical Massachusetts strains H120 
and H52 can produce cross – protection against heterologus field infection (Vo B  et 
al., 1991). Also cross – protection was produced by some IB vaccines against 
antigenically unrelated strains (Winterfield and Fadley, 1875, Rosenberger et al., 
1986  and  Hofstad, 1981). This finding, also was confirmed by Igniatovic and Galli 
(1995) who indicated that even when a variant IBV  is recognized by VN it is 
possible that the existing vaccines may still have some protective effects. Genotypes 
based on N - terminus of the spike protein and the virus dose are essential to IBV 
protection for immunization, thus development of vaccines from different local 
strains is necessary  to control IB in poultry (Lin et al.,  2005). 
1.11.4 Vaccine in Sudan 
 Till 2003 there was no history of vaccination against IB in Sudan except in 4 
farms (in  which birds were reared on a close system) (Ballal, 2003). 
 The control of IB in young chicken is primarily achieved by the use of live 
vaccines. In Sudan, although live vaccine is being used on all large commercial 
farms and many other small farms, outbreaks of IB in all age group are regularly 
diagnosed (Anon, 2000). 
 Live IBV vaccine was produced locally (for the first time) from the 
Massachusetts  type IB vaccine (Ma5), the vaccine was prepared according to the 
requirement of the OIE. The result of serotyping and serosurveillance confirmed the 
existence of IBV strain 4/91, Massachusetts and D274, the vaccine of 4/91 has 
introduced in Sudan, since that time but was not used in Field (Ballal , 2003). 




MATERIALS AND METHODS 
 
2.1 Experimental chickens 
 A number of 225, one day old broiler chicks (Hubbard breed) brought from 
(Mony company for poultry production – Khartoum, Sudan), were  used in the study 
and divided into nine  equal groups (25 chicks per group). Eight groups were 
vaccinated as in Table (1) and one group was left as control without vaccination.  
2.2 Vaccines 
The following vaccines were used in the study: 
i. Live freeze – dried vaccine against IB (Boxmeer, Holland Ma5) (Intervet 
International, commercially supplied by Detasi – company, (Khartoum). 
ii. Live freeze dried  vaccine containing strain (H120), of IB (Medial – Italy) 
which commercially supplied by Coral company (Khartoum). These vaccines 
were employed at different time with different routes, as shown below.  
2.2.1 Vaccination Program 
Two hundred, one –day old , Hubbard chicks were divided into 8 equal 
groups (A, B, C, D, E, F, G and H). These  were vaccinated as shown in table (1) 
2.2.1.1 Intraocular route 
One vial of 1000 doses were dissolved in 30 ml physiological saline solution, 
each chick received 0.030 ml by means of a standardized dropper. 
2.2.1.2 Drinking water administration 
One vial of 1000 doses was dissolved in 16 liters of water to which, 32 gm of 
skimmed milk power were added.(400 ml of the vaccine – medicated water was up 
taken  in two hours)  (These two routes were used in this study). 
 Table (1): The vaccination program  used  for two different vaccine strains, 
different routes  of administration in different times. 

































Group J Control Group without vaccine  
 
I/N = Intraocular. 
D.W = Drinking water.  
Ma5 and H120 = These are IBV vaccine strains. 
5 days and 10 days = chicken age. 
2.3 Blood sampling 
 Blood samples were aseptically taken from the heart, jugular or wing vein of 
all vaccinated and unvaccinated groups. Using one ml sterile disposable syringes, 2.5 
ml blood volumes were taken from five chicks selected randomly from each group 
before vaccination and at 15, 20, 25 days post initial vaccination. The blood samples 
were left to clot in a sloping position at room temperature, the clot was separated, 
sera removed after over night incubation at 4°C  in eppendorff   tubes, and  then 
stored  at 20°C  until used for IBV antibodies  detection by means of ELISA. 
2.4 Body weight observation 
The body weight for all groups of chicks following vaccination was recorded 
and shown  in Table (2). 
2.5 Clinical symptoms and postmortem findings 
Daily observation of clinical symptoms was done with special attention to 
respiratory signs. On postmortem  finding, One bird was selected randomly from 
each group every week, they were killed and the main gross lesions were  noted.                                      
2.6 Enzyme – linked   immunosorbent  assay (ELI SA) kits 
Indirect ELISA kits ( Lab. Hipra, S. A. Spain), for the detection of specific 
antibodies against infectious bronchitis virus (IBV) in chicken serum were used for 
monitoring the immune response to the vaccination trials during this study. (Kits was 
kindly  provided by Central Veterinary Research Laboratory –Khartoum- Sudan ).  
ELISA reagents 
 The ELISA  kits  used contained the following components. 
IBV coated plates  
 The microplate coated with specific IBV antigen.   
Washing solution  
Washing solution (10X) with methylisozolone and bromonitrodioxane 
preservative.                                                                                                       Sample 
diluents 
 Solution (10x) containing green dye. 
   Conjugate solution  
Horse radish peroxides labeled rabbit anti – chicken IgG containing 
stabilizers with methylisothiozolone and bromonitrodioxane preservative and red 
dye.  
Substrate solution (ABTS): 2,2 Azino –bis (3.ethylbenzthioline - 6 - sulforic acid ) 
Stop solution 
 Oxalic acid solution ready to use. 
Positive control:  
 IBV positive control serum pre–diluted and ready to use with 
methylisothizolone and bromonitrodioxane presrervation and yellow dys. 
Negative control: 
 IBV negative control serum pre-diluted and ready to use contain 
methylisothizolone and bromonitrodioxane preservative and blue dye.   
Sample preparation 
Positive and negative controls are ready to use. Each test  serum sample 
(from vaccinated and unvaccinated chickens) was diluted 1:500 by adding 1 µl    of 
the test serum to 0.5 ml  of sample diluents and mixed well. 
Reagent preparation 
All reagents were allowed to come to room temperature before used .   
Swirling to adequate mixing. 
Washing solution (10X) was diluted 1/10 in distilled water. 
Sample diluentsss 10X) was diluted 1/10 in distilled water. 
2.7 ELISA procedure 
 The test was done as described by manufacturer as follows: 
I. IBV coated plates were removed from sealed bag and location of samples 
on template were   recorded.  
II. Fifty µl of negative control serum were placed into wells A1 and A2. 
III. Fifty µl of positive control serum were placed into well A3 and A4.  
IV. Fifty µl of the diluted serum samples were placed into the appropriate wells, 
plates were then covered with lid and incubated at 37°C for 60 minutes. 
V. The contents of each well was then  aspirated and washed 4 times with 
wash solution (300 µl /per well), each plate was inverted and firmly tapped 
dry on absorbent  paper. 
VI. Fifty µl of the conjugate were added into all wells, plates were covered with 
adhesive cover and incubated at 37°C for 60 minutes, then washed 3 times. 
VII. Fifty µl of substrate solution was added to each wells, plates covered with 
adhesive cover and incubated at 37°C for 30 minutes. 
VIII. Fifty µl of the stop solution were added into all wells to stop the  reaction.        
IX. The absorbance of the control serum and serum sample were recorded using 
the microtitre plate reader at 405 nm. 
X. For the test results to be valid the mean OD of the positive control must be 
greater than 0.5 and the ratio (mean OD405 of the positive control/mean 
OD405  of the negative control must be greater than 6.0). 
2.8 Interpretation of results 
Sample to positive (S/P) ratio  
The relative amounts of antibodies in chicken samples were  calculated by 
reference to the positive control sample value related to positive value, (as described 
by the manufacturer) and this relation is expressed as S/P ratio. 
Calculation of S/P ratio 
The following formula was applied (using mean absorbance values for 
control). 
          S/P ratio  =            Sample OD405 – mean OD405 negative control 
                                     Mean OD405 positive control – mean OD405 negative  
 
Samples with an S/P ratio less than or equal to 0.139 are considered negative, 
and samples with an S/P ratio greater than 0.139 are consider positive  for either 
maternally derived antibody (MDA ) or exposure (vaccine or disease). 
 
Calculation of antibody titer 
As stated by the manufacturer the following equation relates the  S/P 
of a sample at 1:500 dilution to an end point titer.  
Log10  Titer = 1.9426x log10 S/P + 4.0215  
Titer = Antilog of log10 titer. 
A titer range of 0-227 was considered negative and a titer 228 or greater 
consider positive (MDA level or exposure vaccine or disease).     
2.9 Data analysis  
Microsoft Excel (Windows 2000 ) was used  for data analysis. In order to find 
out  the relation between  the factors (strains, time  and  route ) and vaccine response 




 3.1 Clinical symptom and  postmortem finding                
Following  vaccination of chicks with either  vaccines, routes and times, no 
clinical signs  observed except coughing, sneezing, severe gasping, nasal discharges 
and diarrhea in the control group with no mortality. Postmortem findings in bird 
randomly selected from each   group are, caseous exudates in the lower part of the 
trachea and sinuses, pneumonia, congested lungs, cloudy air sacs and air sacculitis in 
each vaccinated group. 
3.2 Body weight 
Body weight for all groups of chicks following vaccination was recorded and 
shown in Table (2). When chicks were one old (before vaccination) the  average wt 
was similar for all groups (0.3 kg). Following vaccination of chicks, obvious 
variations in the body wt of chicks were observed, generally 5-day old vaccination 
has lowest effect on wt in all groups (1.8 kg, 1.75 kg, 1.68 kg, 1.6 kg) as camper with 
10 day old vaccination (1.5 kg, 1.3 kg, 1.25 kg, 1.18 kg). While intraocular route has 
lower effect on wt gains and H120 strain has the low effect on wt gain when used at 5 







 Table (2): Body weight of different groups of vaccinated chicks. 
Chickens age    Group  of chicks /Body weight (g).       
  A B C D E F G H J 
At one day old  0.3 * 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 
At 15 days 0.38 ٭ 0.33 0.37 0.31 0.36 0.35 0.45 0.39 0.3 
At 23 days  0.67 • 0.6 0.66 0.58 0.64 0.63 0.7 0.68 0.5 
At 45 days  1.68 1.25 1.6 1.18 1.5 1.3 1.8 1.75 1 
 
    *  : Near body weight of variant.(n =7). 
  :   ٭ Near body weight of variant.(n =5). 







3.3 Screening  of IB antibodies using ELISA 
3.3.1 The effect of vaccines strains and time of administration on antibody level 
The IBV  ELISA titer   of broilers  5 - day old chicks vaccinated with  one 
dose of commercially produced  IB vaccines type Massachusetts, (strain Ma5 and 
H120), using two routes of administration (intraocular and drinking water), were   
increased up  to 4 weeks post vaccination to a high  level.  Higher ELISA  titer  (740) 
was detected 25 days post vaccination, by using H120 strain   in drinking water 
compared with (590) detected  using Ma5 same route and time, and (330) in the 
control  unvaccinated group. (Figure 1). 
 Figure (2)  shows antibody response in chicks vaccinated at 10 day – old. 
Highest  titer (615) obtained by using Ma5 strain through  intraocular route while 
H120 gave lowest titer (524).  
3.3.2 The  effect of  vaccine administration  route  on antibody response post 
vaccination 
Figure (3) compared the routes of the vaccine administration. As for  Ma5 
vaccine intraocular route resulted in higher titer (646), while drinking water resulted 
in lower titer (590). When the same route  (intraocular) were used  with  different 
vaccines strains, at the same time  H120 strain give (680) while Ma5 give (646). ( 
Figure 4) Ma5 strain used at 5 and 10 day - old  via drinking water  result in (590) 
titer at 5day – old  compare with (535)  titer of 10 day – old  (Figure 5). When using 
H120 via intraocular route  at 5 day - old result in (680) and (542) in 10 day – old 
Figure (6). 
3.3.3 The effect of  the vaccines on Maternally   Derived Antibody (MDA)  
Highest result of the whole test was (1091) detected before vaccination  
(MDA) in the group received Ma5 vaccine at 5 day – old result in (590) titer  
(figure7), in contrast (MDA) level at 10 day – old group received the same vaccine 
(475) is lower (Figure 8).  
 
 
Fig. (1): The antibody  response of 5 – days old chicks received one 
dose of two strains IB vaccine as measured by ELISA  
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I/O: Intraocular administration. 
D.W.: Drinking water. 
Ma5: Ma5Vaccine strain. 
H120: H120Vaccine strain.  
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Fig. (2):  The antibody   response of 10 – days old chickens received one dose of  
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Fig. (3): The antibody response of  5 – days old chicks vaccinated  with Ma5 
with Ma5 IB vaccine via I/O and D.W. route.  
 
I/O: Intraocular administration. 
D.W.: Drinking water. 
Ma5: Ma5Vaccine strain. 
PV: Post vaccination.  
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Fig. (4): The antibody  response of 5 – days old chicks vaccinated with 
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I/O: Intraocular administration. 
Ma5: Ma5Vaccine strain. 
H120: H120Vaccine strain.  
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Fig. (5): The antibody response of   vaccination in 5 – 10 days with Ma5 strains,  
via drinking water route.  
 
I/O: Intraocular administration. 
D.W.: Drinking water. 
Ma5: Ma5Vaccine strain. 
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Fig. (6): The antibody response in chicks vaccinated with H120 vaccine strain   
at 5 and 10 days old via I/O route . 
 
I/O: Intraocular administration. 
H120: H120Vaccine strain.  
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Fig. (7): Comparison between MDA and vaccine response of chicks vaccinated 
at 5 day old with Ma5 via drinking water.  
 









D.W.: Drinking water. 
MDA: Maternal derived antibodies.  
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Fig. (8): Comparison between MDA and vaccine response of chicks vaccinated 










Route of vaccine  
I/O: Intraocular administration. 
MDA: Maternal derived antibodies.  




Control of IB in young chicks is primarily achieved by the use of vaccines. 
Several facts must be considered before choosing suitable vaccine strain, which 
should induce protection without causing adverse reaction or disease in chicks (Lin 
et al., 2005). 
The low pathogenesity of the strain choosed  must remain unchangeable, 
therefore, it must be genetically stable to exclude possible reversion. All 
conventional live IB vaccines contain several virus sub population. Each sub 
population may differ in its biological characteristics such as pathogenicity (Anon, 
1998). In the Sudan, although live IB vaccines are used, still outbreaks of the disease 
in all age groups were regularly diagnosed (Ballal, 2003), for this reasons, during this 
study a laboratory trials for evaluating conventional IB vaccines (H120) and cloned IB 
vaccine (Ma5) under Sudan condition were done.                                                                           
The results obtained indicated that, the growth rates of chicks was not 
affected when they vaccinated at 5 days old compared to10 days old vaccination 
protocols. This was obvious when measuring the body weight of chicks following 
vaccination. The vaccine strain H120 was also shown to have low adverse effect on 
the body weight gain of chicks as compared to Ma5 vaccine specially when 
administered through the intraocular route. This substantiates the previous results of 
Cook and Huggind (1986) who stated that, IBV depress weight gain and had an 
adverse effect on feed conversion ratio. 
The main clinical signs observed in the unvaccinated chicks were recorded as 
respiratory signs, nasal discharge, conjunctivitis and inflamed sinuses  (Butcher and 
Miles 1991),  in the present study when chicks were subjected to postmortem 
examination, no obvious gross lesions were observed among unvaccinated  control  
group, while pneumonia, congested lungs, trachietis were detected in the vaccinated 
group similar  result was obtained by Cavanagh (1991). 
In the present study, ELISA technique was used for monitoring the antibody 
responses after vaccination because its important for evaluation of the 
immunological response after vaccination in the disease control programs and in the 
diagnosis of IB in the field [Nagano et al., 1990).The antibody responses of broiler 
chicks vaccinated with one dose of either Ma5 or H120 were increased 4 weeks  post 
vaccination at high levels. Highest antibody level was observed in the first 5 days 
before vaccination, because of MDA. However, Hofstad (1984) found that  the  
MDA does not  prevent the infection of chicks with IBV but  reduced the pathogenic 
effects of infection, so although the vaccine cut and decrease MDA., to certain level, 
its used for protection. Chickens that received H120 in drinking water at 5 day showed 
higher antibody (ELISA titer 740) compared with (ELISA titer 590) of those 
received the same vaccine via the same route at 10 days – old , this result indicated 
that good immunological response was given even when vaccine was used in chicks 
with high level of MDA and also confirmed  that H120 strain of IB has the ability to 
provide heterologous cross protection against a number of IBVs of different 
serotypes (Bijlenge et al., 2004), 4/91 strain and Massachusetts which antigenically 
different were reported in Sudan. Balall isolate  strain 4/91 in (2003) and 
Massachusetts was reported by Borhan (1995). The lowest level of antibodies 
responses was detected in the control unvaccinated   group (ELISA titer 330) near to 
negative level (227) followed by group that received H120 strain at 10 day – old 
(relatively low maternal antibody), in drinking water (ELISA titer  461), this 
illustrated that the initial proper vaccination time is  first week this confirmed result 
of  Mockett  et al. (1987) who found maternal antibody that protect against challenge 
at one week but not two weeks of age.  
This result demonstrate the suitability of ELISA test as a sensitive (sensitive 
to all variant and gives a good level of signal to antibodies resulting from  
heterologous strain), rapid  serological  test, for IBV antibodies detection. 
              The data obtain  from  the study can be concluded in  Massachusets vaccine 
strain (H120 and Ma5) were immunogenic with less clinical symptoms and efficient 
even when used in chicks with high maternal antibody,                            
H120 strain does affect weight gain at 5 day – old vaccination via drinking water, and 
the most suitable time for collecting sera to detect significant positive antibody 
response of IBV with high ELISA test seem to be 4 weeks post initial vaccination 
when all groups demonstrated high titers (≥228 ), also concluded that  
 time of vaccination had influenced the effectiveness of vaccines and ELISA proved  
efficient in the detection of IB antibodies. 
Recommendations   
Based on the results of  the present study, and due to the genetic  instability of 
IBV (New serotyps  appear  from time to time ). This complicate disease control,  so 
the following recommendations must be considered.  
1) Massachusetts vaccines  serotypes (H120 and Ma5)  must be used  at  one day- 
old (1-5 day) broiler chicks. 
2) H120 strain is  safe and efficient  when used as initial vaccine, and it can also 
be used when ever time of vaccine is lost.  
3) Drinking water route of administration is easy and  useful  rather than 
intraocular one. 
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